Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

被引:36
|
作者
Honda, Yasushi [1 ]
Yoneda, Masato [1 ]
Imajo, Kento [1 ]
Nakajima, Atsushi [1 ]
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 2360004, Japan
关键词
elastography; non-alcoholic fatty liver disease; vibration-controlled transient elastography; point shear wave elastography; two-dimensional shear wave elastography; magnetic resonance elastography; MAGNETIC-RESONANCE ELASTOGRAPHY; RADIATION FORCE IMPULSE; SHEAR-WAVE ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; NONINVASIVE DIAGNOSIS; HEPATIC STEATOSIS; MR ELASTOGRAPHY; NAFLD FIBROSIS;
D O I
10.3390/ijms21114039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is expected to increase in prevalence because of the ongoing epidemics of obesity and diabetes, and it has become a major cause of chronic liver disease worldwide. Liver fibrosis is associated with long-term outcomes in patients with NAFLD. Liver biopsy is recommended as the gold standard method for the staging of liver fibrosis. However, it has several problems. Therefore, simple and noninvasive methods for the diagnosis and staging of liver fibrosis are urgently needed in place of biopsy. This review discusses recent studies of elastography techniques (vibration-controlled transient elastography, point shear wave elastography, two-dimensional shear wave elastography, and magnetic resonance elastography) that can be used for the assessment of liver fibrosis in patients with NAFLD.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [31] Role of liver biopsy in the assessment of non-alcoholic fatty liver disease
    Hübscher, SG
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (11) : 1107 - 1115
  • [32] Hypertension and non-alcoholic fatty liver disease proven by transient elastography
    Wang, Yaohui
    Zeng, Yuhua
    Lin, Changwei
    Chen, Zhiheng
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (13) : 1304 - 1310
  • [33] Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease
    Liguori, Antonio
    Zoncape, Mirko
    Tsochatzis, Emmanuel A.
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (04) : 191 - 194
  • [34] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [35] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [36] Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
    Armandi, Angelo
    Michel, Maurice
    Gjini, Kamela
    Emrich, Tilman
    Bugianesi, Elisabetta
    Schattenberg, Jorn M. M.
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, : 771 - 782
  • [37] Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
    Basheer, Maamon
    Naffaa, Mohamed
    Assy, Nimer
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 398 - 400
  • [38] Fibrosis progression and mortality in non-alcoholic fatty liver disease
    Elfwen, Olof
    Stal, Per
    Hultcrantz, Rolf W.
    Hagstrom, Hannes
    [J]. HEPATOLOGY, 2016, 64 : 531A - 531A
  • [39] Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
    Han, Eugene
    [J]. DIABETES & METABOLISM JOURNAL, 2022, 46 (04) : 564 - 566
  • [40] Ruling out fibrosis in non-alcoholic fatty liver disease
    Tavabie, Oliver D.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 355